Cell 77, 551563
We focused on selected signaling pathways known for being regulated by GLP1RA including cAMP pathway, NF-B pathway, PI3K pathway, Adipocytokine and adiponectin pathways and other related to interactions with -arrestin, CAV1, DPP4, ALB, RAMPs and NEP 34,35,36,37,38
Following 4 days of dosing with 6 tablets of levocarnitine 330 mg b.i.d
Rare but Serious Risks: Serious adverse events are uncommon, but the class has a few important considerations: Pancreatitis: Post-marketing reports linked GLP-1 RAs to cases of acute pancreatitis
We used Ca 2+ imaging with Fura-2 to test whether exendin-4 could change [Ca 2+ ] i in dissociated GCs
doi: 10.1016/j.cca.2020.05.041 237 SallenaveJ.-M.GuillotL